Thema
Journal Article
1.612
PARP inhibitors
1.202
PARP inhibitor
1.178
Poly(ADP-ribose) Polymerase Inhibitors
832
Review
696
Research Support, Non-U.S. Gov't
471
Antineoplastic Agents
356
olaparib
340
Ovarian cancer
299
ovarian cancer
283
EC 2.4.2.30
279
Phthalazines
254
BRCA1 Protein
243
BRCA
225
Poly(ADP-ribose) Polymerases
207
WOH1JD9AR8
206
Piperazines
196
BRCA2 Protein
192
Olaparib
184
BRCA1 protein, human
172
DNA repair
166
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
155
BRCA2 protein, human
137
Research Support, N.I.H., Extramural
135
BRCA1
124
breast cancer
116
Breast cancer
115
BRCA2
114
niraparib
107
Poly (ADP-Ribose) Polymerase-1
106
immunotherapy
104
rucaparib
101
prostate cancer
96
homologous recombination
95
talazoparib
91
PARP Inhibitor
90
DNA damage repair
86
DNA damage
84
synthetic lethality
84
BRCA mutation
83
Biology (General)
78
Case Reports
77
Immunotherapy
75
Niraparib
75
veliparib
75
PARP1 protein, human
74
DNA damage response
72
Synthetic lethality
72
Biomarkers, Tumor
65
Bevacizumab
64
mehr ...